Sp155
UPDATE ON THE PATHOGENESIS OF PSC-IBD: IS THE GUT-LIVER AXIS REAL?
Date
May 18, 2024
Presenter
Tracks
Related Products
ASSESSMENT OF A PASSIVE MONITORING DEVICE TO TRACK FLARES IN INDIVIDUALS WITH CROHN'S DISEASE
BACKGROUND: Anti-granulocyte macrophage-colony stimulating factor autoantibodies (anti-GM-CSF) have been associated with development of Crohn’s disease (CD) and complications at time of diagnosis. There are limited data on anti-GM-CSF as a prognostic biomarker in CD…
CHARACTERIZING EPITOPES AND ISOTYPES OF CROHN'S DISEASE-ASSOCIATED ANTI-GRANULOCYTE MACROPHAGE-COLONY STIMULATING FACTOR ANTIBODIES.
Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) maintains mononuclear phagocytes (MNP) and supports intestinal immune homeostasis. Anti-GM-CSF autoantibodies (aGMAbs) are found in approx. 25% of all Crohn’s disease (CD) patients…
DECIPHERING THE POTENTIAL CRITICAL LINK BETWEEN VIRUSES AND GM-CSF AUTOANTIBODIES IN PREDICTING CROHN'S DISEASE COMPLICATIONS
Anti-granulocyte/macrophage-colony stimulating factor autoantibody (GM-CSF AuAB) has been identified before the onset of Crohn’s Disease (CD) and is associated with an increase in complicated disease. However, its connection to the gut microbiome, a key factor in CD progression, remains unclear…
RNA SEQUENCING FROM BIOPSIES PERFORMED DURING FOOD ELIMINATION AND REINTRODUCTION IDENTIFIES SIGNATURES INVOLVED IN EARLY RECURRENCE OF EOE
RATIONALE: RNA sequencing studies have previously identified impaired barrier function and the subsequent proinflammatory response as critical to the pathogenies of EoE. However, the investigation into disease initiation is often limited by the inability to capture the disease early…
